C: Placebo

DRUG2 trials

Sponsors

Ferring Pharmaceuticals, OliPass Australia Pty Ltd

Conditions

NocturiaOsteoarthritis

Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Multiple Subcutaneous Doses of OLP-1002

CompletedNCT04677933

OliPass Australia Pty LtdOsteoarthritis

Start: 2020-06-03End: 2020-12-22Updated: 2020-12-24

Phase 2

Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women

CompletedNCT01684800

Ferring PharmaceuticalsNocturia

Start: 2012-09-30End: 2013-06-30Updated: 2013-08-23